HSD17B13-IN-37 is a selective inhibitor of 17β-Hydroxysteroid dehydrogenase type 13 (HSD17B13), demonstrating an IC50 of less than 0.1 μM for estradiol. This compound is utilized in research focused on nonalcoholic fatty liver disease (NAFLD), where it aids in elucidating the role of HSD17B13 in lipid metabolism and liver pathophysiology. Its potent inhibitory activity makes it a valuable tool for investigating therapeutic strategies targeting HSD17B13-related pathways.
HSD17B13-IN-37 is a selective inhibitor of 17β-Hydroxysteroid dehydrogenase type 13 (HSD17B13), demonstrating an IC50 of less than 0.1 μM for estradiol. This compound is utilized in research focused on nonalcoholic fatty liver disease (NAFLD), where it aids in elucidating the role of HSD17B13 in lipid metabolism and liver pathophysiology. Its potent inhibitory activity makes it a valuable tool for investigating therapeutic strategies targeting HSD17B13-related pathways.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
